The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...
Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.
Investors with a lot of money to spend have taken a bearish stance on Humana HUM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...
Humana provides three types of Medicare coverage options for Medicare users. Its Medigap plans are designed to help seniors afford the cost of healthcare by covering items not traditionally ...
Humana is a widely available Medicare Advantage provider, but star ratings have slipped from last year. Many, or all, of the products featured on this page are from our advertising partners who ...
Humana beat Wall Street estimates for third-quarter profit on Wednesday, buoyed by strength in its government-backed Medicare Advantage insurance business for older adults.
Humana (NYSE:HUM) increased its annual membership guidance for its Medicare Advantage business with its Q3 2024 financials on Wednesday despite facing a series of setbacks for the segment this ...
Cigna said it isn't seeking to buy Humana, bolstering its stock and weighing on the share price of the Medicare-focused company. Cigna spoke out because of ongoing speculation it would strike a deal ...
Humana Inc. issued a more optimistic 2024 forecast after third-quarter profit exceeded expectations, breaking with larger peers that have struggled to contain medical costs. Adjusted earnings of $ ...
Resource specialist MJ Ryan answers calls at the Arden Hills office of Trellis, a nonprofit that's one of several groups across the state that field Senior LinkAge Line calls on Thursday. (Glen ...
Humana (HUM) and Longevity Health, a clinical services company dedicated to serving vulnerable individuals living in a long-term care facility, have announced that eligible residents of long-term ...
For 2025, Humana said it expects adjusted profit to be at least in line with final 2024 results. Analysts expect a 2025 profit of $19.77 per share, according to data compiled by LSEG.